↓ Skip to main content

Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges

Overview of attention for article published in Molecular Cancer, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#37 of 1,889)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
6 news outlets
twitter
2 X users
facebook
1 Facebook page

Readers on

mendeley
67 Mendeley
Title
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Published in
Molecular Cancer, October 2021
DOI 10.1186/s12943-021-01422-7
Pubmed ID
Authors

Daolin Tang, Guido Kroemer, Rui Kang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 16%
Student > Bachelor 6 9%
Student > Ph. D. Student 6 9%
Professor 4 6%
Other 3 4%
Other 6 9%
Unknown 31 46%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 14 21%
Medicine and Dentistry 7 10%
Agricultural and Biological Sciences 4 6%
Chemistry 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 5 7%
Unknown 32 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2022.
All research outputs
#862,236
of 25,067,172 outputs
Outputs from Molecular Cancer
#37
of 1,889 outputs
Outputs of similar age
#20,213
of 428,092 outputs
Outputs of similar age from Molecular Cancer
#2
of 35 outputs
Altmetric has tracked 25,067,172 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,889 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,092 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.